http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2218922-C2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 1999-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d608b437aefc25b8bbf4a7186086975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_487337a2c6f1059693c3d195a990fbf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e5402eede146f4b898a14cd94b96bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6ac934460f9292810937dd8db5ad133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fce52a08e4cd2fddca438f681c9111ba
publicationDate 2003-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2218922-C2
titleOfInvention Compounds comprising in structure fragment of derivative of glucuronic acid and fragment of derivative of glucosamine, method for preparing these compounds and application of these compounds
abstract FIELD: medicine, biochemistry, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition used as anti-thrombocyte agent comprising derivative of glucuronic acid, agents for promotion of growth of vascular endothelial cells comprising derivative of glucuronic acid. EFFECT: enhanced effectiveness of agent. 6 cl, 10 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707533-B2
priorityDate 1998-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456029861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157

Total number of triples: 40.